Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients

被引：0

作者：

Jean Claude Alvarez

Pierre Moine

Benjamin Davido

Isabelle Etting

Djillali Annane

Islam Amine Larabi

Nicolas Simon

机构：

[1] Raymond Poincaré Hospital,Department of Pharmacology and Toxicology, Paris

[2] AP-HP,Saclay University (Versailles Saint

[3] Hôpital Raymond Poincaré,Quentin

[4] AP-HP,en

[5] Raymond Poincaré hospital,Yvelines), Inserm U

[6] AP-HP,1173, FHU Sepsis

[7] Raymond Poincaré hospital,Laboratoire de Pharmacologie

[8] AP-HP,Toxicologie, Université de Versailles Saint

[9] Aix-Marseille University,Quentin

来源：

European Journal of Clinical Pharmacology | 2021年 / 77卷

关键词：

Lopinavir; Pharmacokinetics; Covid-19;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：389 / 397

页数：8

共 50 条

[41] Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients
Kalantari, Saeed
Fard, Soheil R.
Maleki, Donya
Taher, Mahshid T.
Yassin, Zeynab
Alimohamadi, Yousef
Minaeian, Sara
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (12) : 6557 - 6565
[42] Population pharmacokinetics of favipiravir in patients with COVID-19
Irie, Kei
Nakagawa, Atsushi
Fujita, Hirotoshi
Tamura, Ryo
Eto, Masaaki
Ikesue, Hiroaki
Muroi, Nobuyuki
Fukushima, Shoji
Tomii, Keisuke
Hashida, Tohru
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (10): : 1161 - 1170
[43] Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review
Vargas, M.
Servillo, G.
Einav, S.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (16) : 8592 - 8605
[44] Lopinavir/Ritonavir for COVID-19: a Systematic Review and Meta-Analysis
Amani, Bahma
Khanijhani, Ahmad
Amani, Behnam
Hashemi, Payam
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2021, 24 : 246 - 257
[45] A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
Joumaa, H.
Regard, L.
Carlier, N.
Chassagnon, G.
Alabadan, E.
Canoui, E.
L'honneur, A.
Rozenberg, F.
Burgel, P. -R.
Roche, N.
RESPIRATORY MEDICINE AND RESEARCH, 2020, 78
[46] Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19
Chong, Vui Heng
Chong, Pui Lin
Metussin, Dhiya
Asli, Rosmonaliza
Momin, Riamiza Natalie
Mani, Babu Ivan
Abdullah, Muhammad Syafiq
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2322 - 2324
[47] DRUG-VIRUS INTERACTION: LOPINAVIR 1 RITONAVIR AND COVID-19
Ozaybi, M.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S417 - S417
[48] IN-SILICO MODELLING STUDIES ON RITONAVIR AND LOPINAVIR TO COMBAT COVID-19
Tuteja, Jasdev Singh
Chitnis, Kshitij
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (10): : 5247 - 5253
[49] A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B.
Wang, Y.
Wen, D.
Liu, W.
Wang, Jingli
Fan, G.
Ruan, L.
Song, B.
Cai, Y.
Wei, M.
Li, X.
Xia, J.
Chen, N.
Xiang, J.
Yu, T.
Bai, T.
Xie, X.
Zhang, L.
Li, C.
Yuan, Y.
Chen, H.
Li, Huadong
Huang, H.
Tu, S.
Gong, F.
Liu, Y.
Wei, Y.
Dong, C.
Zhou, F.
Gu, X.
Xu, J.
Liu, Z.
Zhang, Y.
Li, Hui
Shang, L.
Wang, K.
Li, K.
Zhou, X.
Dong, X.
Qu, Z.
Lu, S.
Hu, X.
Ruan, S.
Luo, S.
Wu, J.
Peng, L.
Cheng, F.
Pan, L.
Zou, J.
Jia, C.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1787 - 1799
[50] Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review
Joseph, Betsy Ann
Dibas, Mahmoud
Evanson, Kirk W.
Paranjape, Geeta
Vegivinti, Charan Thej Reddy
Selvan, Pragadeesh Thamarai
Saravu, Kavitha
Gupta, Nitin
Pulakurthi, Yashwitha Sai
Keesari, Praneeth Reddy
Varsha, Sriram
Chittajallu, Spandana
Dmytriw, Adam A.
Reierson, Natalie L.
Mikoff, Nick
Kamrowski, Shelby
Schmidt, Megan
Davis, Amber R.
Pederson, John M.
Mishra, Hemant K.
Touchette, Jillienne C.
Kallmes, Kevin
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (06) : 679 - 687

← 1 2 3 4 5 →